Thermo Fisher Scientific Inc., the world leader in serving science, today announced an informative webinar to help users of inductively coupled plasma (ICP) technologies prepare for the introduction of the proposed United States Pharmacopeia (USP) chapters 232 and 233 on trace elemental impurities in pharmaceutical products. The educational presentation provides the pharmaceutical industry with valuable information about how ICP techniques can facilitate compliance with these emerging legislative requirements. The webinar, entitled "Preparing for the Proposed United States Pharmacopeia Chapters on Trace Elemental Impurities in Pharmaceuticals with ICP Techniques," is now available to view on-demand at www.spectroscopynow.com/webinars. 

Presented by Matthew Cassap, senior ICP applications specialist for Thermo Fisher Scientific, the comprehensive webinar discusses the limitations of the current USP method governing the analysis of heavy metals in pharmaceutical products. In addition, the webinar provides a historical background and detailed overview of the proposed new chapters.  

The presentation features the Thermo Scientific iCAP 6000 Series ICP spectrometer, demonstrating the efficiency of ICP techniques for the reproducible analysis of trace elemental impurities in pharmaceuticals in compliance with the upcoming regulatory requirements. In addition, Thermo Scientific iTEVA Security Software plays a crucial role in legislative compliance efforts as it allows for optimization of instrument parameters and elimination of interferences, delivering maximum accuracy and reliability of results. The webinar will also discuss other elemental analysis techniques and how these can be utilized for the analysis of trace elemental impurities in pharmaceuticals.  

Matthew Cassap comments: "The latest Thermo Scientific webinar is essential for pharmaceutical scientists who need to stay up-to-date with elemental analysis techniques and, in particular, ICP-OES and ICP-MS methodologies in order to meet future legislative requirements in pharmaceutical analysis. The proposed USP chapters mark a new era for the analysis of trace elemental impurities in pharmaceutical products and the industry must get ready for the change. The Thermo Scientific range of ICP-OES and ICP-MS instrumentation enables users to comply with the regulatory additions while delivering accurate and repeatable results." 

For more information about Thermo Scientific trace elemental analyzers for the pharmaceutical industry, please call +1 800-532-4752, or visit www.thermoscientific.com/trace.   

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.